Evidence map›Paper›PMID 24679531›Full record

ReviewCell2014

Role of the microbiota in immunity and inflammation.

Yasmine Belkaid, Timothy W Hand

6 registry-linked trialsAbstract readReview
In one paragraph

Review in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 2,968 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,968citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046432 nacompletednot on this mapstarted 2017, after this paper: background citation

Effects of Vigiis 101-LAB on Gut Health

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2017 to 2018Enrolled54ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT04088474 nacompletednot on this mapstarted 2016, after this paper: background citation

Functional Assessment in The Intestinal Flora Improvement

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2016 to 2016Enrolled36ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT04884776 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Modulation of Gut Microbiota to Enhance Health and Immunity of Vulnerable Individuals During COVID-19 Pandemic

TypeinterventionalSponsorChinese University of Hong KongRan2021 to 2024Enrolled453ConditionsGut Microbiota, COVID-19 VaccineArmsMicrobiome immunity formula, Active placebo
NCT05808101 terminatednot on this mapstarted 2022, after this paper: background citation

Role of the Gut Microbiome as Determinant of Depression in Multiple Sclerosis Subjects

TypeobservationalSponsorWashington University School of MedicineRan2022 to 2024Enrolled51ConditionsMultiple Sclerosis, DepressionArmsNeuro-QoL T-score determination
NCT05812820 nacompletednot on this mapstarted 2022, after this paper: background citation

Research of Change of Microbial System Intestines and Efficacy for Probiotic Treatment of Persistent Diarrhea in Children

TypeinterventionalSponsorNational Children's Hospital, VietnamRan2022 to 2024Enrolled165ConditionsDiarrheaArmsLiveSpo DIA30, LiveSpo CLAUSY, RO
NCT07184684 phase2 / phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS): A Randomized , Placebo Controlled Cross Over Trial

TypeinterventionalSponsorRegion SkaneRan2024 to 2031Enrolled50ConditionsChronic Rhinosinusitis Without Nasal Polyps, Chronic Rhinosinusitis With Nasal PolypsArmsSinonasal microbiome transplant procedure., Placebo saline transplant
3 · Its place in the literature

Who cites it

2,968 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Long-Term Efficacy ofNutrients · 2026
    Trial
  9. Synthetic and systems biotechnology · 2027
    Review
  10. Article
  11. Article
  12. Gut microbes · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

2,908 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yasmine BelkaidImmunity at Barrier Sites Initiative, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: ybelkaid@niaid.nih.gov.
Timothy W HandImmunity at Barrier Sites Initiative, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.

Funding

Role of the microbiota in immunityZIAAI001115 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2009 to 2025
$22.4M
Intramural NIH HHS ZIA AI001115
6 · The paper itself

Abstract

The microbiota plays a fundamental role on the induction, training, and function of the host immune system. In return, the immune system has largely evolved as a means to maintain the symbiotic relationship of the host with these highly diverse and evolving microbes. When operating optimally, this immune system-microbiota alliance allows the induction of protective responses to pathogens and the maintenance of regulatory pathways involved in the maintenance of tolerance to innocuous antigens. However, in high-income countries, overuse of antibiotics, changes in diet, and elimination of constitutive partners, such as nematodes, may have selected for a microbiota that lack the resilience and diversity required to establish balanced immune responses. This phenomenon is proposed to account for some of the dramatic rise in autoimmune and inflammatory disorders in parts of the world where our symbiotic relationship with the microbiota has been the most affected.

Indexed as

Immune SystemMicrobiotaAnimalsAnti-Bacterial AgentsBacteriaBacterial Physiological PhenomenaFungiHumansInflammationSymbiosisAnti-Bacterial Agents

Identifiers

PMID24679531
PMCPMC4056765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.